Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women.

OBJECTIVE Because studies suggest that ultraviolet (UV) radiation modulates the myositis phenotype and Mi-2 autoantigen expression, we conducted a retrospective investigation to determine whether UV radiation may influence the relative prevalence of dermatomyositis and anti-Mi-2 autoantibodies in the US. METHODS We assessed the relationship between surface UV radiation intensity in the state of residence at the time of onset with the relative prevalence of dermatomyositis and myositis autoantibodies in 380 patients with myositis from referral centers in the US. Myositis autoantibodies were detected by validated immunoprecipitation assays. Surface UV radiation intensity was estimated from UV Index data collected by the US National Weather Service. RESULTS UV radiation intensity was associated with the relative proportion of patients with dermatomyositis (odds ratio [OR] 2.3, 95% confidence interval [95% CI] 0.9-5.8) and with the proportion of patients expressing anti-Mi-2 autoantibodies (OR 6.0, 95% CI 1.1-34.1). Modeling of these data showed that these associations were confined to women (OR 3.8, 95% CI 1.3-11.0 and OR 17.3, 95% CI 1.8-162.4, respectively) and suggests that sex influences the effects of UV radiation on autoimmune disorders. Significant associations were not observed in men, nor were UV radiation levels related to the presence of antisynthetase or anti-signal recognition particle autoantibodies. CONCLUSION This first study of the distribution of myositis phenotypes and UV radiation exposure in the US showed that UV radiation may modulate the clinical and immunologic expression of autoimmune disease in women. Further investigation of the mechanisms by which these effects are produced may provide insights into pathogenesis and suggest therapeutic or preventative strategies.

[1]  C. Burd,et al.  UV Radiation Regulates Mi-2 through Protein Translation and Stability* , 2008, Journal of Biological Chemistry.

[2]  G. Halliday,et al.  UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. , 2008, The Journal of investigative dermatology.

[3]  W. Ollier,et al.  The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis , 2007, Annals of the rheumatic diseases.

[4]  F. Miller,et al.  Mechanisms of Disease: environmental factors in the pathogenesis of rheumatic disease , 2007, Nature Clinical Practice Rheumatology.

[5]  Tim K. Lee,et al.  Adverse effects of ultraviolet radiation: a brief review. , 2006, Progress in biophysics and molecular biology.

[6]  I. Lundberg,et al.  Pathogenesis of idiopathic inflammatory myopathies , 2006, Current rheumatology reports.

[7]  V. Hearing,et al.  Human skin responses to UV radiation: pigment in the upper epidermis protects against DNA damage in the lower epidermis and facilitates apoptosis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Sergio G Coelho,et al.  Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation. , 2005, The Journal of investigative dermatology.

[9]  H. Piazena,et al.  Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects , 2004, Photodermatology, photoimmunology & photomedicine.

[10]  Hiroshi Tanaka,et al.  Effect of 17β-estradiol on immunosuppression induced by ultraviolet B irradiation , 2004, Archives of Dermatological Research.

[11]  S. Okada,et al.  Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. , 2003, Arthritis and rheumatism.

[12]  G. Murphy Ultraviolet radiation and its effects on the immune system , 2000, Clinical and experimental dermatology.

[13]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[14]  A. Masi Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[15]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.